2551 studies found for:    "Bacterial Infections"
Show Display Options
Rank Status Study
21 Recruiting Pharmacokinetics and Safety of Solithromycin Capsules in Adolescents
Condition: Bacterial Infections
Intervention: Drug: Solithromycin
22 Terminated
Has Results
A Study of Ceftobiprole in Patients With Fever and Neutropenia.
Conditions: Fever;   Neutropenia;   Gram-positive Bacterial Infections;   Pseudomonas Infection
Interventions: Drug: Ceftobiprole Medocaril;   Drug: Cefepime with or without vancomycin
23 Recruiting A Single Dose Study To Investigate The Pharmacokinetics and Safety Of Dalbavancin In Hospitalized Children Aged 3 Months to 11 Years.
Condition: Bacterial Infections.
Intervention: Drug: Dalbavancin
24 Completed Safety, Pharmacokinetics (PK) and Tolerability Study of a Novel Drug for Treatment of Bacterial Infections
Condition: Gram-negative Bacterial Infection
Interventions: Drug: AN3365;   Drug: Placebo
25 Completed Daptomycin for the Treatment of Infections Due to Gram-Positive Bacteria
Condition: Gram-Positive Bacterial Infections
Intervention: Drug: daptomycin
26 Completed An Evaluation Of Three Dose Levels Of 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) In Healthy Adults
Conditions: Bacterial Infections;   Staphylococcal Vaccines;   Immunotherapy, Active;   Staphylococcal Skin Infections;   Staphylococcal Infections
Interventions: Biological: SA3Ag vaccine;   Procedure: Blood draw;   Procedure: Colonization swab samples;   Biological: SA3Ag followed by Placebo;   Biological: Placebo;   Biological: SA3Ag with no booster in stage 2;   Procedure: Placebo with no booster in stage 2
27 Completed Evaluation of Two Type III GBS Polysaccharide-Tetanus Toxoid Conjugate Vaccines
Conditions: Bacterial Infections;   Group B Streptococcus
Interventions: Biological: GBS III-TT-SSI;   Biological: GBS III-TT-MPHL
28 Completed PROcalcitonin Reduce Antibiotic Treatments in Acute-Ill Patients (PRORATA)
Condition: Bacterial Infections
Intervention: Procedure: Procalcitonin guided strategy
29 Completed Study Comparing Tigecycline to Imipenem/Cilastatin in Complicated Intra-Abdominal Infections in Hospitalized Subjects
Conditions: Gram-Positive Bacterial Infections;   Cross Infection
Intervention: Drug: Tigecycline
30 Completed Study Evaluating Vancomycin-Resistant Enterococci in a Hematology Unit
Condition: Gram-Positive Bacterial Infections
Intervention: Drug: Piperacillin/tazobactam and other β-lactam/β-lactamase
31 Completed Study Evaluating Tigecycline in Selected Serious Infections Caused by Vancomycin-Resistant Enterococcus (VRE) or Methicillin-Resistant Staphylococcus Aureus (MRSA)
Conditions: Gram-Positive Bacterial Infections;   Staphylococcus Infections;   Vancomycin Resistance;   Methicillin Resistance
Intervention: Drug: Tigecycline
32 Completed Study Evaluating Tigecycline in Selected Serious Infections Due to Resistant Gram-Negative Organisms
Condition: Gram-Negative Bacterial Infections
Intervention: Drug: tigecycline
33 Recruiting Multicenter Open-label Randomized Controlled Trial (RCT) to Compare Colistin Alone Versus Colistin Plus Meropenem
Condition: Gram-Negative Bacterial Infections
Interventions: Drug: Colistin;   Drug: Meropenem
34 Completed A Study of the Safety and Effectiveness of Levofloxacin Compared With Lomefloxacin in the Treatment of Complicated Urinary Tract Infections
Conditions: Urinary Tract Infections;   Bacterial Infections;   Bacteriuria;   Urologic Diseases
Intervention: Drug: Levofloxacin
35 Completed Study Evaluating Emergency-use Tigecycline in Subjects With Resistant Pathogens.
Condition: Bacterial Infections
Intervention: Drug: Tigecycline
36 Recruiting Safety and Pharmacokinetics of Clindamycin in Pediatric Subjects With BMI ≥ 85th Percentile
Conditions: Bacterial Infections;   Obesity
Intervention: Drug: Clindamycin
37 Completed Phase I Study of the Clinical Pharmacology of Azithromycin in Buffy Coat of HIV-Infected Subjects.
Conditions: Bacterial Infections;   HIV Infections
Intervention: Drug: Azithromycin
38 Completed A Study of Azithromycin in HIV-Infected Patients
Conditions: Bacterial Infections;   HIV Infections
Intervention: Drug: Azithromycin
39 Completed Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic Fibrosis
Conditions: Cystic Fibrosis;   Bacterial Infections
Intervention: Drug: mucoid exopolysaccharide P. aeruginosa immune globulin IV
40 Completed Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic Antibiotics
Condition: Gram Positive Bacterial Infection
Intervention: Drug: Daptomycin

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years